Thierry Lecomte

14.5k total citations · 2 hit papers
254 papers, 6.5k citations indexed

About

Thierry Lecomte is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Thierry Lecomte has authored 254 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Oncology, 81 papers in Pulmonary and Respiratory Medicine and 63 papers in Surgery. Recurrent topics in Thierry Lecomte's work include Colorectal Cancer Treatments and Studies (64 papers), Gastric Cancer Management and Outcomes (48 papers) and Pancreatic and Hepatic Oncology Research (43 papers). Thierry Lecomte is often cited by papers focused on Colorectal Cancer Treatments and Studies (64 papers), Gastric Cancer Management and Outcomes (48 papers) and Pancreatic and Hepatic Oncology Research (43 papers). Thierry Lecomte collaborates with scholars based in France, United States and Canada. Thierry Lecomte's co-authors include Pierre Laurent‐Puig, Bruno Landi, Philippe Beaune, Jean‐Christophe Olivo‐Marín, Alexandre Dufour, Praveen Pankajakshan, Stéphane Dallongeville, Yoann Le Montagner, Nicolas Hervé and Vannary Meas‐Yedid and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Thierry Lecomte

232 papers receiving 6.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Icy: an open bioimage informatics platform for extended reproducible research

2012 1.0k citations Thierry Lecomte et al. profile →
Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer

2009 529 citations Pierre Laurent‐Puig, Anne Cayre et al. Journal of Clinical Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Thierry Lecomte	3.1k	1.5k	1.4k	1.4k	999	254	6.5k
Takashi Nakajima	3.4k 1.1×	3.1k 2.1×	2.7k 1.9×	2.0k 1.4×	1.1k 1.1×	281	8.7k
Qin Huang	1.9k 0.6×	1.4k 1.0×	3.1k 2.2×	1.7k 1.2×	819 0.8×	288	7.6k
Rupert Langer	2.3k 0.7×	2.7k 1.8×	2.5k 1.8×	2.6k 1.9×	466 0.5×	219	7.7k
E. Neely Atkinson	1.8k 0.6×	1.7k 1.1×	1.8k 1.3×	1.1k 0.8×	577 0.6×	122	6.9k
Maurice B. Loughrey	2.3k 0.7×	1.1k 0.7×	1.8k 1.3×	991 0.7×	760 0.8×	99	6.7k
Masahiko Watanabe	5.3k 1.7×	3.5k 2.4×	2.0k 1.4×	4.1k 2.9×	1.1k 1.1×	405	11.2k
Lai Wei	2.2k 0.7×	852 0.6×	1.3k 0.9×	1.1k 0.8×	689 0.7×	277	6.0k
Atsushi Kubo	1.8k 0.6×	2.0k 1.4×	3.4k 2.4×	2.3k 1.6×	456 0.5×	335	10.0k
Shunsuke Kondo	2.8k 0.9×	1.2k 0.8×	2.0k 1.4×	1.5k 1.1×	382 0.4×	410	7.2k
Silvano Bòsari	2.8k 0.9×	1.7k 1.1×	4.6k 3.2×	1.4k 1.0×	1.2k 1.2×	189	9.4k

Countries citing papers authored by Thierry Lecomte

Since Specialization

Citations

This map shows the geographic impact of Thierry Lecomte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Lecomte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Lecomte more than expected).

Fields of papers citing papers by Thierry Lecomte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Lecomte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Lecomte. The network helps show where Thierry Lecomte may publish in the future.

Co-authorship network of co-authors of Thierry Lecomte

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Lecomte. A scholar is included among the top collaborators of Thierry Lecomte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Lecomte. Thierry Lecomte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Daigneault, Isabelle, et al.. (2025). Adverse childhood experiences, social functioning deficits and comorbid clinical symptoms among individuals with psychotic disorders: A prospective cohort study. Schizophrenia Research. 283. 27–35.

Ducreux, Michel, Yves Rinaldi, Frédéric Di Fiore, et al.. (2025). PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma. Journal of Clinical Oncology. 43(20). 2255–2264. 3 indexed citations

Mestier, Louis de, Magalie Haissaguerre, Pauline Afchain, et al.. (2024). Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network. Journal of Nuclear Medicine. 65(2). 258–263. 8 indexed citations

Meurisse, Aurélia, Pascal Artru, Thierry Lecomte, et al.. (2024). 517P Circulating tumor DNA driving anti-EGFR rechallenge therapy in metastatic colorectal cancer: The RASINTRO prospective multicenter study. Annals of Oncology. 35. S438–S438. 1 indexed citations

Cancel, Mathilde, et al.. (2024). FASTOCH: Feasibility of Electronic Patient-Reported Outcomes in Older Patients With Cancer—A Multicenter Prospective Study. Journal of Clinical Oncology. 42(22). 2713–2722. 7 indexed citations

Dupré, Aurélien, Pascal Artru, Antoine Drouillard, et al.. (2024). Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study. Digestive and Liver Disease. 56(9). 1605–1613.

Roth, Gaël S., Anna Pellat, Guillaume Piessen, et al.. (2024). A simple prognostic score to predict recurrence after pancreaticoduodenectomy for ampullary carcinoma: results from the French prospective FFCD-AC cohort. ESMO Open. 9(12). 103988–103988.

Caulet, Morgane, Olivier Bouché, Christophe Borg, et al.. (2024). Evaluation of serum mid-infrared spectroscopy as new prognostic marker for first-line bevacizumab-based chemotherapy in metastatic colorectal cancer. Digestive and Liver Disease. 57(1). 141–148. 1 indexed citations

Walter, Thomas, Thierry Lecomte, Julien Hadoux, et al.. (2023). LBA54 Alkylating agent-based vs oxaliplatin-based chemotherapy in neuroendocrine tumours according to the O6-methylguanine-DNA methyltransferase (MGMT) status: A randomized phase II study (MGMT-NET) on behalf of the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network. Annals of Oncology. 34. S1292–S1293. 5 indexed citations

10.

Lepage, Côme, Astrid Lièvre, Laëtitia Dahan, et al.. (2022). Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study. European Journal of Cancer. 175. 31–40. 13 indexed citations

11.

Hautefeuille, Vincent, Louis de Mestier, Clélia Coutzac, et al.. (2022). Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study. International Journal of Cancer. 152(9). 1894–1902. 2 indexed citations

12.

Aparicio, Thomas, Karine Le Malicot, Michel Ducreux, et al.. (2021). Predictive factors of severe early treatment-related toxicity in patients receiving first-line treatment for metastatic colorectal cancer: Pooled analysis of 2190 patients enrolled in Fédération Francophone de Cancérologie Digestive (FFCD) trials. European Journal of Cancer. 153. 40–50. 4 indexed citations

13.

Desvignes, Céline, David Ternant, Thierry Lecomte, et al.. (2021). A Robust Enzyme-Linked Immunosorbent Assay to Measure Serum Ramucirumab Concentrations. Bioanalysis. 13(7). 565–574. 2 indexed citations

14.

Flament, Thomas, et al.. (2020). Cross-Cultural Adaptation and Psychometric Validation of the French Version of the FAMCARE-Patient (FFP-16) Questionnaire for Outpatients With Advanced-Stage Cancer. Journal of Pain and Symptom Management. 60(1). 94–100.e1. 1 indexed citations

15.

Jary, Marine, Angélique Vienot, Romain Loyon, et al.. (2020). Molecular description of ANGPT2 associated colorectal carcinoma. International Journal of Cancer. 147(7). 2007–2018. 22 indexed citations

16.

Gallois, Claire, Pascal Artru, Astrid Lièvre, et al.. (2019). Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study. European Journal of Cancer. 119. 35–43. 28 indexed citations

17.

Jary, Marine, Déwi Vernerey, Thierry Lecomte, et al.. (2015). Prognostic Value of Angiopoietin-2 for Death Risk Stratification in Patients with Metastatic Colorectal Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 24(3). 603–612. 16 indexed citations

18.

Brieau, Bertrand, Céline Lepère, Thomas Walter, et al.. (2015). Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma. Medicine. 94(42). e1864–e1864. 24 indexed citations

19.

Aparicio, Thomas, Jean–Louis Jouve, Laurent Teillet, et al.. (2013). Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First-Line Chemotherapy for Metastatic Colorectal Cancer in Elderly Patients. Journal of Clinical Oncology. 31(11). 1464–1470. 154 indexed citations

20.

Laurent‐Puig, Pierre, Anne Cayre, Gilles Manceau, et al.. (2009). Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer. Journal of Clinical Oncology. 27(35). 5924–5930. 529 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact